4 ms·
Ivermectin is incredibly effective. It's just not profitable. Here is a meta analysis of 63 (so far) randomized double blind trials: https://ivmmeta.com/ https
by willmadden 5y ago
Ivermectin is incredibly effective. It's just not profitable.
Here is a meta analysis of 63 (so far) randomized double blind trials: https://ivmmeta.com/ https://ivmmeta.com/
- lucd 5y agoNot peer reviewed, not published, anonymous authors. This is a fake meta-analysis. The most important study that weighted in IVM favor was bogus and was retracted some days ago.
- willmadden 5y agoIf you don't like the meta analysis, then sample underlying (cited) studies. I have and didn't find any misrepresentations. Ivermectin looks like a great drug to repurpose as an outpatient therapy for COVID-19.
- raphlinus 5y agoHere's a scientific paper which presents the case that your link is misleading: https://ebm.bmj.com/content/early/2021/05/26/bmjebm-2021-111678 https://ebm.bmj.com/content/early/2021/05/26/bmjebm-2021-111...
- willmadden 5y agoThere are direct links to the underlying studies. I've read about a dozen of them randomly, and I didn't find any misrepresentations. Are you claiming that Ivermectin isn't effective as a repurposed outpatient therapy for COVID-19?